NEWS
Evonik invests in Chinese vegan collagen maker Jland Biotech
German personal care giant Evonik has invested in Chinese vegan collagen maker Jland Biotech as part of a partnership to develop new products.
Financial details was not
disclosed but Evonik said it has invested via its venture capital group through Jland Biotech’s series round-B financing. In addition, the two companies
have signed a business cooperation agreement that will focus on the development and restructuring of new collagen protein products. The partnership will enable
Evonik to provide commercial quantities of collagen for applications in skincare such as anti-ageing and hydrating creams. The new collagen products,
manufactured in collaboration with Jland, will be launched later this year, expanding Evonik’s
existing product portfolio of vegan collagen. Evonik recently launched its
own vegan collagen Vecollage Fortify L for cosmetic and personal care applications. “Evonik’s life sciences division is using its biotechnology platform to leverage the expertise of its partners and collaborate on precision biosolutions. We welcome Jland to our partner network,” said Johann-Caspar Gammelin, Evonik’s president of its Nutrition & Care division. “Together with our expertise
in active ingredients and delivery systems, we are creating a world- leading portfolio of non-animal derived collagen,” he added. Jland Biotech is a company
dedicated to developing and manufacturing non-animal- derived collagen. It was founded in 2015 and has its headquarters
The job cuts come after Evonik
posted a 2023 net loss of €465m as sales fell by 17% to €15.3 billion. The German chemicals giant
said the redundancies would include a “disproportionate” number of management positions. The majority of these lay-offs, around 1,500 jobs, will be made in Germany.
The number of hierarchical
in Jingjiang, China. Jland’s core technology is
centred around a production process that incorporates efficiency and scalability. In a related development,
Evonik is to cut up to 2,000 jobs worldwide by the end of 2026 in an effort to make annual cost savings of €400m ($435m).
levels below its executive board will be reduced to a maximum of six, while review and approval procedures will be significantly accelerated. Group-wide, managers will
then lead a median of seven direct reports, compared to the current span of control of one to four. Around 80% of the annual
€400m savings expected by the end of 2026 will be personnel reductions, the rest will come from lower non-personnel costs.
Elementis to open Portugal R&D lab, centre of excellence
British personal care ingredient maker Elementis is to open a centre of excellence and R&D laboratory in Portugal, as well as hire 100 staff. Headquartered in Porto, the
new unit will support both of Elementis’ business segments – Personal Care and Performance Specialties, and is scheduled to open in the second half of 2024. By the end of 2024,
Elementis expects to invest up to €3m ($3.25m) in Portugal to
open the new unit, in addition to the expected annual investment of up to €6m in people and facilities. The company will hire 100
skilled employees for the project – among which professionals in research & development, marketing and commercial areas to support the personal care business. Teams in Porto will perform
product development and technical services activities, and will provide customer support
for the skincare, colour cosmetics and antiperspirant markets. For some roles, the company will offer
relocation support. “Elementis’ new location
in Porto will be an open and inspiring space for our employees and customers to collaborate on practical demonstrations, presentations and training,” said Elementis CEO Paul Waterman. “We have ambitious plans
to launch more than 50 new products by 2026, and this new location will play a crucial role in realizing those plans,” he added.
Exsymol partners with DKSH to conquer Canada
Monaco actives maker Exsymol has signed an exclusive agreement with DKSH for the marketing and distribution of its products in Canada. DKSH will provide business
development, marketing, sales, logistics, and distribution services for Exsymol’s range of silanols, peptides and natural actives designed for skin care, cosmetics/ dermocosmetic applications.
www.personalcaremagazine.com Silanols from Exsymol are a
range of cosmetic actives that have a core of organic silicium. Silanols reload the skin with silicium and therefore delay the appearance of aging signs as well as offer rejuvenation benefits to the skin for long-term results. Exsymol produces batches
from 50 kg to 5 tons of active ingredients in accordance with international standards, including
ISO, GMP-ci, and EcoVadis. Ori Callot, commercial and
marketing director of Exsymol Monaco, said: “Belief and trust are the elements for a successful partnership; we believe, together with the skills and the long experience of DKSH in distribution and our high-quality ingredients, we will be able to support our customers and respond to the market needs in Canada.”
April 2024 PERSONAL CARE
9
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154
